Park Avenue Securities’s Vericel VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$231K Sell
5,751
-169
-3% -$7.32K ﹤0.01% 1659
2026
Q2
$263K Buy
+5,920
New +$213K ﹤0.01% 1582
2025
Q3
– Sell
-5,717
Closed -$243K – 1690
2025
Q2
$243K Buy
+5,717
New +$238K ﹤0.01% 1362
2025
Q1
– Sell
-5,099
Closed -$280K – 1516
2024
Q4
$280K Buy
+5,099
New +$258K ﹤0.01% 1308
2024
Q3
– Sell
-4,923
Closed -$226K – 1449
2024
Q2
$226K Sell
4,923
-119
-2% -$5.61K ﹤0.01% 1279
2024
Q1
$262K Buy
+5,042
New +$221K ﹤0.01% 1223

Other funds holding VCEL

Park Avenue Securities's VCEL Position: Q3 2026 in Review

Park Avenue Securities reduced its Vericel (VCEL) stake by 2.9% in Q3 2026, selling an estimated $7.32K and leaving 5,751 shares worth $231K. The position accounts for ﹤0.01% of the portfolio, ranked #1659.

Park Avenue Securities first reported a position in VCEL in Q1 2024 and has held it in 6 quarters since. The position peaked at $280K in Q4 2024. 320 funds tracked by Wall St. Rank hold VCEL as of Q3 2026.

  • Park Avenue Securities held 5,751 shares of Vericel worth $231K as of Q3 2026.
  • Park Avenue Securities sold 169 Vericel shares in Q3 2026, an estimated $7.32K.
  • Vericel made up ﹤0.01% of Park Avenue Securities's portfolio in Q3 2026, its #1659 holding.
  • Park Avenue Securities first reported a position in Vericel in Q1 2024 and has held it in 6 quarters since.
  • Park Avenue Securities's Vericel position peaked at $280K in Q4 2024.
  • 320 funds tracked by Wall St. Rank held Vericel as of Q3 2026.

Based on Park Avenue Securities's 13F filing for Q3 2026, filed 26 Oct 2026.